ATE246514T1 - Paclitaxel enthaltende arzneimittel - Google Patents
Paclitaxel enthaltende arzneimittelInfo
- Publication number
- ATE246514T1 ATE246514T1 AT99945661T AT99945661T ATE246514T1 AT E246514 T1 ATE246514 T1 AT E246514T1 AT 99945661 T AT99945661 T AT 99945661T AT 99945661 T AT99945661 T AT 99945661T AT E246514 T1 ATE246514 T1 AT E246514T1
- Authority
- AT
- Austria
- Prior art keywords
- products containing
- medicinal products
- containing paclitaxel
- paclitaxel
- long term
- Prior art date
Links
- 229930012538 Paclitaxel Natural products 0.000 title abstract 2
- 229960001592 paclitaxel Drugs 0.000 title abstract 2
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/165,930 US5922754A (en) | 1998-10-02 | 1998-10-02 | Pharmaceutical compositions containing paclitaxel |
| PCT/US1999/021024 WO2000020036A1 (en) | 1998-10-02 | 1999-09-14 | Pharmaceutical compositions containing paclitaxel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE246514T1 true ATE246514T1 (de) | 2003-08-15 |
Family
ID=22601068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99945661T ATE246514T1 (de) | 1998-10-02 | 1999-09-14 | Paclitaxel enthaltende arzneimittel |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5922754A (de) |
| EP (1) | EP1117440B1 (de) |
| JP (1) | JP2002526424A (de) |
| AT (1) | ATE246514T1 (de) |
| AU (1) | AU759034B2 (de) |
| CA (1) | CA2345729A1 (de) |
| DE (1) | DE69910230T2 (de) |
| DK (1) | DK1117440T3 (de) |
| ES (1) | ES2205879T3 (de) |
| PT (1) | PT1117440E (de) |
| WO (1) | WO2000020036A1 (de) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2005927A1 (en) * | 1988-12-21 | 1990-06-21 | Chander Bahl | Method of preparing nucleotide probes using a bridging complement |
| US6774278B1 (en) | 1995-06-07 | 2004-08-10 | Cook Incorporated | Coated implantable medical device |
| KR100330373B1 (ko) * | 1996-05-28 | 2002-11-07 | 주식회사한국신약 | 탁솔을 함유한 주사용 약제 조성물 |
| KR19990075621A (ko) * | 1998-03-23 | 1999-10-15 | 임성주 | 경사 평판형 배양조 |
| US6017948A (en) * | 1998-10-30 | 2000-01-25 | Supergen, Inc. | Water-miscible pharmaceutical compositions |
| US6071952A (en) * | 1998-12-02 | 2000-06-06 | Mylan Pharmaceuticals, Inc. | Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents |
| US6136846A (en) * | 1999-10-25 | 2000-10-24 | Supergen, Inc. | Formulation for paclitaxel |
| JP2003521545A (ja) | 2000-02-02 | 2003-07-15 | フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド | 改良された溶解性を有するタキサン製剤 |
| US8618085B2 (en) * | 2000-04-28 | 2013-12-31 | Koasn Biosciences Incorporated | Therapeutic formulations of desoxyepothilones |
| AU5887201A (en) | 2000-05-12 | 2001-11-20 | Samyang Corp | Method for the preparation of polymeric micelle via phase separation of block copolymer |
| US7217770B2 (en) * | 2000-05-17 | 2007-05-15 | Samyang Corporation | Stable polymeric micelle-type drug composition and method for the preparation thereof |
| DE10115740A1 (de) | 2001-03-26 | 2002-10-02 | Ulrich Speck | Zubereitung für die Restenoseprophylaxe |
| KR100774366B1 (ko) * | 2001-09-10 | 2007-11-08 | 주식회사 중외제약 | 파클리탁셀 주사제 조성물 |
| AU2002351169B2 (en) * | 2001-11-26 | 2007-09-20 | Intas Pharmaceuticals Limited | Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions |
| US20060078618A1 (en) * | 2001-12-11 | 2006-04-13 | Constantinides Panayiotis P | Lipid particles and suspensions and uses thereof |
| DE10244847A1 (de) | 2002-09-20 | 2004-04-01 | Ulrich Prof. Dr. Speck | Medizinische Vorrichtung zur Arzneimittelabgabe |
| ES2368941T3 (es) * | 2003-01-06 | 2011-11-23 | Angiochem Inc. | Angiopep-1, compuestos relacionados y utilizaciones correspondientes. |
| RU2408605C2 (ru) * | 2005-02-18 | 2011-01-10 | Анджиокем Инк. | Полипептид, способный преодолевать гематоэнцефалический барьер, и его конъюгат |
| US20090016959A1 (en) * | 2005-02-18 | 2009-01-15 | Richard Beliveau | Delivery of antibodies to the central nervous system |
| JP2008543789A (ja) * | 2005-06-17 | 2008-12-04 | ホスピラ オーストラリア ピーティーワイ エルティーディー | ドセタキセルの液体薬学的処方物 |
| PL2233156T3 (pl) * | 2005-07-15 | 2013-09-30 | Angiochem Inc | Zastosowanie polipeptydów aprotyninowych jako nośników w koniugatach farmaceutycznych |
| AR054215A1 (es) | 2006-01-20 | 2007-06-13 | Eriochem Sa | Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit |
| CL2007003145A1 (es) * | 2006-10-31 | 2008-01-25 | Wyeth Corp | Composicion farmaceutica que comprende un compuestos derivado de indol y un sistema portador que comprende 10-50% de un primer solubilizante, 10-50% de un segundo solubilizante y 10-30% de un diluyente; proceso de preparacion; y forma farmaceutica. |
| US9365634B2 (en) * | 2007-05-29 | 2016-06-14 | Angiochem Inc. | Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues |
| WO2009047794A2 (en) * | 2007-10-01 | 2009-04-16 | Intas Pharmaceuticals Limited | Taxane derivative composition |
| AR063111A1 (es) | 2007-10-03 | 2008-12-30 | Eriochem Sa | Una formulacion farmaceutica de taxano |
| US20090098168A1 (en) * | 2007-10-08 | 2009-04-16 | The Regents Of The University Of California | Multiple-layer microbubble liposphere drug delivery vehicle and system |
| KR101053780B1 (ko) * | 2008-02-29 | 2011-08-02 | 동아제약주식회사 | 도세탁셀을 함유하는 단일액상의 안정한 약제학적 조성물 |
| JP5860698B2 (ja) * | 2008-04-18 | 2016-02-16 | アンジオケム，インコーポレーテッド | パクリタキセル、パクリタキセル類似体またはパクリタキセルコンジュゲートの医薬組成物ならびに関連する調製方法および使用方法 |
| ES2344674B1 (es) | 2008-08-07 | 2011-06-29 | Gp Pharm, S.A. | Composicion farmaceutica inyectable de taxanos. |
| WO2010023321A1 (en) * | 2008-09-01 | 2010-03-04 | Stragen Pharma S.A. | Liquid formulation containing a taxane derivative |
| JP5705118B2 (ja) | 2008-10-15 | 2015-04-22 | アンジオケム インコーポレーテッド | 薬物送達のためのエトポシドおよびドキソルビシン複合体 |
| EP2346906A4 (de) | 2008-10-15 | 2013-04-24 | Angiochem Inc | Konjugate aus glp-1-agonisten und ihre verwendung |
| JP5759379B2 (ja) | 2008-12-05 | 2015-08-05 | アンジオケム インコーポレーテッド | ニューロテンシンまたはニューロテンシンアナログおよびその使用 |
| US7862716B2 (en) * | 2009-04-13 | 2011-01-04 | Sielc Technologies Corporation | HPLC schematic with integrated sample cleaning system |
| EP2421562B1 (de) | 2009-04-20 | 2019-03-13 | Angiochem Inc. | Behandlung von ovarialkarzinom mit einem an ein angiopep-2-analogon konjugierten antitumorwirkstoff |
| RU2012103240A (ru) | 2009-07-02 | 2013-08-10 | Ангиокем Инк. | Мультимерные пептидные конъюгаты и их применение |
| FR2948568B1 (fr) * | 2009-07-30 | 2012-08-24 | Sanofi Aventis | Formulation pharmaceutique |
| CN102151243B (zh) * | 2010-12-29 | 2013-06-05 | 辰欣药业股份有限公司 | 一种紫杉醇注射液及其制备方法 |
| CN103330941B (zh) * | 2013-07-15 | 2014-11-19 | 贺金凤 | 一种紫杉醇注射剂的药物组合物 |
| US9763892B2 (en) | 2015-06-01 | 2017-09-19 | Autotelic Llc | Immediate release phospholipid-coated therapeutic agent nanoparticles and related methods |
| CA2989400A1 (en) | 2015-06-15 | 2016-12-22 | Angiochem Inc. | Ang1005 for the treatment of leptomeningeal carcinomatosis |
| TWI752750B (zh) * | 2015-09-30 | 2022-01-11 | 香港商慧源香港創新有限公司 | 口服紫杉烷組合物及方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3243393A (en) * | 1991-12-10 | 1993-07-19 | Rush - Presbyterian - St. Luke's Medical Center | Methods and compositions for reducing multi-drug resistance |
| CA2149150C (en) * | 1992-11-27 | 2000-08-01 | David R. Carver | Injectable taxol composition with improved stability |
| FR2698543B1 (fr) * | 1992-12-02 | 1994-12-30 | Rhone Poulenc Rorer Sa | Nouvelles compositions à base de taxoides. |
| TW406020B (en) * | 1993-09-29 | 2000-09-21 | Bristol Myers Squibb Co | Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent |
| WO1996011007A1 (en) * | 1994-10-05 | 1996-04-18 | Glaxo Wellcome Inc. | Parenteral pharmaceutical compositions containing gf120918a |
| US5681846A (en) * | 1995-03-17 | 1997-10-28 | Board Of Regents, The University Of Texas System | Extended stability formulations for paclitaxel |
| AU724842B2 (en) * | 1995-12-21 | 2000-09-28 | Genelabs Technologies, Inc. | Taxane composition and method |
| SK284511B6 (sk) * | 1997-07-29 | 2005-05-05 | Pharmacia & Upjohn Company | Samoemulgujúce formulácie pre lipofilné zlúčeniny |
-
1998
- 1998-10-02 US US09/165,930 patent/US5922754A/en not_active Expired - Fee Related
-
1999
- 1999-09-14 PT PT99945661T patent/PT1117440E/pt unknown
- 1999-09-14 EP EP99945661A patent/EP1117440B1/de not_active Expired - Lifetime
- 1999-09-14 ES ES99945661T patent/ES2205879T3/es not_active Expired - Lifetime
- 1999-09-14 AU AU58225/99A patent/AU759034B2/en not_active Ceased
- 1999-09-14 DE DE69910230T patent/DE69910230T2/de not_active Expired - Fee Related
- 1999-09-14 AT AT99945661T patent/ATE246514T1/de not_active IP Right Cessation
- 1999-09-14 CA CA002345729A patent/CA2345729A1/en not_active Abandoned
- 1999-09-14 WO PCT/US1999/021024 patent/WO2000020036A1/en not_active Ceased
- 1999-09-14 JP JP2000573394A patent/JP2002526424A/ja not_active Withdrawn
- 1999-09-14 DK DK99945661T patent/DK1117440T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| DK1117440T3 (da) | 2003-12-01 |
| JP2002526424A (ja) | 2002-08-20 |
| ES2205879T3 (es) | 2004-05-01 |
| WO2000020036A1 (en) | 2000-04-13 |
| US5922754A (en) | 1999-07-13 |
| DE69910230D1 (de) | 2003-09-11 |
| CA2345729A1 (en) | 2000-04-13 |
| AU759034B2 (en) | 2003-04-03 |
| DE69910230T2 (de) | 2004-06-09 |
| EP1117440B1 (de) | 2003-08-06 |
| EP1117440A1 (de) | 2001-07-25 |
| AU5822599A (en) | 2000-04-26 |
| PT1117440E (pt) | 2003-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE246514T1 (de) | Paclitaxel enthaltende arzneimittel | |
| IT1318649B1 (it) | Composizioni farmaceutiche per il trattamento di mucositi e stomatiti. | |
| BR0207961A (pt) | Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas | |
| DK0960107T3 (da) | 6-Thiosubstituerede paclitaxeler | |
| FI964681A0 (fi) | Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt | |
| NO20012774D0 (no) | Preparat og metode hvor det gjöres bruk av eteriske planteoljer | |
| DK1329456T3 (da) | Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme | |
| ATE231872T1 (de) | Thiazolopyrimidinderivate | |
| TR200103575T2 (tr) | Sülfonamid ve sülfamid ikameli/katkılı imidazokinolinler | |
| CY1105896T1 (el) | Χρησιμοποιηση ιδεβενονης δια την προστασια σκευασματων | |
| SE9201628D0 (sv) | Pharmaceutical composition | |
| ATE324150T1 (de) | Körperpflegemittel | |
| SE9904377D0 (sv) | Pharmaceutical combinations | |
| ATE322901T1 (de) | Maca und geweih zur steigerung des testosteronspiegels | |
| DK1330258T3 (da) | Kahalalid F-formulering | |
| ES2180319T3 (es) | Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos. | |
| SE9802937D0 (sv) | Novel compounds | |
| TR200402070T4 (tr) | Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı | |
| NO20032597L (no) | Anvendelse av SARP-1 for behandlingen og/eller forebyggingen av skleroderma | |
| ATE305517T1 (de) | Neurotrypsin | |
| SE0001916D0 (sv) | Novel formulation | |
| IT1318401B1 (it) | Derivati di n-desacetiltiocolchicina e composizioni farmaceutiche cheli contengono. | |
| ATE228300T1 (de) | Wirkstoffhaltige polyetherblockamide | |
| NO20021429L (no) | 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner | |
| ATE250340T1 (de) | 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1117440 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |